Bentham Science Logo

Track Your Manuscript:

Current Neuropharmacology

Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access


Current Neuropharmacology, Volume 12 - Number 5

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks

, 12(5): 387 - 398

Maximilian Gahr

DOI: 10.2174/1570159X12999140619122914

Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult

, 12(5): 399 - 412

Joline Goossens and Said Hachimi-Idrissi

DOI: 10.2174/1570159X12666140424233036

Relevance of Excitable Media Theory and Retinal Spreading Depression Experiments in Preclinical Pharmacological Research

, 12(5): 413 - 433

V.M. Fernandes de Lima and W. Hanke

DOI: 10.2174/1570159X12666140630190800

The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target

, 12(5): 434 - 443

Keiko Takanami and Hirotaka Sakamoto

DOI: 10.2174/1570159X12666140923201432

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

, 12(5): 444 - 461

Gianluca Serafini, Robert H. Howland, Fabiana Rovedi, Paolo Girardi and Mario Amore

DOI: 10.2174/1570159X12666140619204251

The Endocannabinoid/Endovanilloid System and Depression

, 12(5): 462 - 474

Irena Smaga, Beata Bystrowska, Dawid Gawlinski, Edmund Przegalinski and Malgorzata Filip

DOI: 10.2174/1570159X12666140923205412


Ferdinando Nicoletti
University Rome"da Sapienza"
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook

Neurobiology of Mood Disorders

You can view the contents of this eBook [here] or purchase it [here].



Related Journals

Related eBooks

eBooks Catalog